A recent trial showed its new 2-for-1 injection was more effective on both illnesses than existing individual shots.
Our daily email brings you smart and engaging news and analysis on the biggest stories in business and finance. For free.
The regulator sees some patents as ploys to keep companies from developing cheaper generic versions of 20 different brand-name drugs.
On Friday, Beijing announced that a trade-in program that previously applied to big appliances and cars will now be widened to smartphones.
As the New Year rolls in, Wall Street is preparing for a slew of listing announcements from private equity-backed firms.
It’s understandable if you failed to notice one meaty if unglamorous trend on Wall Street: Private equity’s love affair with franchising.